Shelly Simana's research lies at the intersection of bioethics and law, addressing ethical and legal challenges that arise as a consequence of scientific advancements in genetics, reproductive technologies, and biotechnology. Central to her research are two intertwined questions: what impact do advances in genetics, reproduction, and biotechnology have on individuals and society; and, how does the law shape this impact? These advances hold the potential to revolutionize health and well-being鈥攂ut only if the law is set on a path that allows them to do so.
Simana鈥檚 scholarship has appeared or is forthcoming in the听Arizona Law Review,听UC Irvine Law Review,听Yale Journal of Law & Technology,听Journal of Law, Medicine & Ethics,听Journal of Law and the Biosciences,听Journal of Medical Ethics,听Bioethics, and听Current Stem Cell Reports. Her work has been cited by both the New York State Supreme Court and the Israeli Supreme Court, and she has been quoted and interviewed by major media outlets, including the听New York Times,听Bloomberg,听MIT Technology Review, and听The Atlantic.
Prior to joining 亚色影库 Law, Simana was a postdoctoral fellow at the Center for Law and the Biosciences at Stanford Law School, as well as a doctoral candidate at Harvard Law School. While pursuing her doctoral degree, Simana served as a teaching fellow at Harvard Law School, Harvard Medical School, and the Harvard T.H. Chan School of Public Health. She was also a research associate in the Program on Science, Technology, and Society (STS) at the Harvard Kennedy School of Government. Prior to her doctoral studies, Shelly was a visiting scholar in the Department of Bioethics at the National Institutes of Health (NIH), a clerk in Israel's High Court of Justice Department at the State Attorney鈥檚 Office, and an associate attorney at S. Horowitz & Co., focusing on health law regulation.
